SCHEMBL1043141

SCHEMBL1043141

CCCC(=O)N(CC)CCC(=O)OCN1C=C2C(=O)N(C3CCN(C(=O)OC(C)(C)C)CC3)CN2C1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.37
GPR119 Q8TDV5 8/20 0.33
PDE4A P27815 1/20 0.33
PDE4B Q07343 1/20 0.33
PDE4C Q08493 1/20 0.33
PDE4D Q08499 1/20 0.33
HCAR1 Q9BXC0 1/20 0.33
FPR2 P25090 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
LMNA P02545 1/20 0.32
THRB P10828 1/20 0.32
USP30 Q70CQ3 1/20 0.32
CTSD P07339 1/20 0.31
CTSE P14091 1/20 0.31
BACE1 P56817 1/20 0.31
KDM4E B2RXH2 1/20 0.31
PKM P14618 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL948928 0.94 TP53 (0.38) TP53GPR119HCAR1FPR2L3MBTL1
SCHEMBL949040 0.92 TP53 (0.38) TP53GPR119HCAR1FPR2THRB
SCHEMBL947774 0.91 TP53 (0.38) TP53GPR119PDE4APDE4BPDE4C
SCHEMBL950563 0.90 TP53 (0.38) TP53GPR119PDE4APDE4BPDE4C
SCHEMBL948503 0.86 TP53 (0.36) TP53GPR119PDE4APDE4BPDE4C
SCHEMBL948340 0.85 TP53 (0.39) TP53GPR119HCAR1FPR2THRB
SCHEMBL948473 0.81 TP53 (0.40) TP53GPR119FPR2L3MBTL1THRB
SCHEMBL947849 0.81 TP53 (0.37) TP53GPR119PDE4APDE4BPDE4C
SCHEMBL949370 0.80 TP53 (0.39) TP53GPR119FPR2L3MBTL1KDM4E
SCHEMBL948169 0.79 TP53 (0.40) TP53GPR119HCAR1FPR2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110009389-A1 IMIDAZOLE DERIVATIVE, THEIR PRODUCTION AND USE TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-01-13 US disclosed
US-20070004736-A1 Imidazole derivative, process for producing the same, and use TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-01-04 US disclosed
EP-1564213-A1 IMIDAZOLE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND USE Takeda Pharmaceutical Company Limited (JP) 2005-08-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070004736-A1 Imidazole derivative, process for producing the same, and use HRH4, F2, HRH2 TP53 4661/4885GPR119 1327/4885PDE4A 4746/4885
US-20110009389-A1 IMIDAZOLE DERIVATIVE, THEIR PRODUCTION AND USE F2, H1-3, CYC1 TP53 4591/4885GPR119 1118/4885PDE4A 4770/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.